CollPlant Biotechnologies Ltd

We are a regenerative and aesthetic medicine company developing innovative technologies and products for medical aesthetics, tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology known to us for mass production of Type I recombinant human collagen (rhCollagen), which is bioidentical to the collagen produced by the human body based on our trials. We believe our proprietary rhCollagen serves as the ideal building block for regenerative medicine. By harnessing its unique biological and mechanical properties, combined with our advanced biomaterials expertise, we are developing a broad pipeline of products for medical aesthetics and 3D bioprinting of tissues and organs. Our legal and commercial name is CollPlant Biotechnologies Ltd. Our name has changed several times but has been CollPlant Biotechnologies Ltd. since June 21, 2019. We hold all of the issued and outstanding shares of CollPlant Ltd. CollPlant Ltd. was incorporated in Israel on August 12, 2004 as a private company limited by shares and began its operations as a technology incubator company under the IIA’s technology incubators program. CollPlant Ltd. owns all of our intellectual property. CollPlant Ltd. holds all of the issued and outstanding shares of CollPlant Inc. CollPlant Inc. was incorporated in Delaware on November 30, 2021, as a corporation. CollPlant Biotechnologies Ltd. was incorporated in Israel on November 9, 1981 as a private company limited by shares.